Board of Directors

Dr. Amit Kumar, Ph.D
Dr. Amit Kumar, Ph.D Chairman, President & Chief Executive Officer

Dr. Kumar, the inventor of our Cchek™ technology, has been an investor, founder, director and CEO of several technology enterprises, both public and private. As CEO, he took CombiMatrix Corporation public and ran it for a decade while listed on the NASDAQ Global Market. He has worked in venture capital ...

Read More

Dr. Arnold Baskies, Ph.D
Dr. Arnold Baskies, Ph.D Director

Dr. Baskies, Chairman of the National Board of Directors of the American Cancer Society, is a board certified general surgeon and fellowship trained surgical oncologist with special interests in breast cancer, thyroid cancer, and melanoma. Dr. Baskies currently has been a member of  Virtua Surgical Specialists, a multi-specialty practice since ...

Read More

Dr. John Monahan, Ph.D
Dr. John Monahan, Ph.D Director

Dr. Monahan is an experienced CEO-level executive and has served on a number of biotechnology company boards over the years. He is currently a Scientific Advisory Consultant for Synthetic Biologics, Inc. (NYSE MKT: SYN) and from 2010 through 2015 he was the Sr. Executive Vice President of Research & Development ...

Read More

Dale Fox
Dale Fox Director

Mr. Fox is an accomplished entrepreneur and innovator who has successfully launched five companies and brought over 25 hardware and software products to market. He is currently the CEO of Tribogenics, a start-up company he co-founded in 2011 that develops portable, powerful X-ray devices based upon a new technology conceived ...

Read More

Lew Titterton
Lew Titterton Director

Mr. Titterton previously served as a Director from August 2010 through August 2016, the last four years of which as Chairman of the Board. He also served as a Director from July 1999 to January 2003. Mr. Titterton's background is in high technology with an emphasis on health care. He ...

Read More

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

The Wistar Institute and ITUS Corporation Renew Collaborative Research Agreement


Lew Titterton re-joins ITUS Corporation's Board of Directors


ITUS Appoints Dr. Amit Kumar as New CEO and Announces Management Changes


Cancer Fact: 27% of global cancer deaths occur in China.